AsymBio, a biologics CDMO, introduced its Conjugation Toolbox to support customized and scalable process development for next-generation bioconjugates like antibody-drug conjugates (ADCs). This platform offers flexible conjugation methods, including random and site-specific technologies, to optimize product quality and manufacturing readiness. It enables rapid process development timelines of 2-3 months for IND-enabling programs and supports complex formats such as bispecific and dual-payload ADCs. The toolbox also integrates purification and impurity removal strategies, facilitating efficient scale-up and GMP manufacturing under strict safety controls.
Lululemon invested in Syntetica's $30 million Series A funding to support its innovative recycling of Nylon 6 and Nylon 6,6, materials difficult to separate and reuse in textile waste. This move aligns with growing industry demand for sustainable, co...
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
